UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 SOLICITATION/RECOMMENDATION...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER STATEMENT...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
AMSTERDAM, THE NETHERLANDS and BRIDGEWATER, NJ -- (Marketwire) -- 01/20/11 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical...
AMSTERDAM, THE NETHERLANDS and BRIDGEWATER, NJ -- (Marketwire) -- 01/19/11 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical...
MILAN, ITALY, and ZURICH, SWITZERLAND -- (Marketwire) -- 01/12/11 -- Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, and...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO TENDER OFFER...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.